![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/444 | |
A61K 31/506 | |||
A61K 45/06 | |||
A61P 37/00 | |||
C07D 401/04 | |||
C07D 403/04 | |||
C07D 409/04 | |||
C07D 413/14 |
(11) | Patento numeris | 3200787 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15846218.4 |
Europos patento paraiškos padavimo data | 2015-09-25 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-08-09 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-04 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2015/052111 |
Data | 2015-09-25 |
(87) | Numeris | WO 2016/053771 |
Data | 2016-04-07 |
(30) | Numeris | Data | Šalis |
201462057692 P | 2014-09-30 | US |
(72) |
ALTMAN, Michael D., US
ANDRESEN, Brian M., US
BRUBAKER, Jason D., US
CHILDERS, Matthew L., US
DONOFRIO, Anthony, US
FISCHMANN, Thierry, US
GIBEAU, Craig R., US
KATTAR, Solomon D., US
LESBURG, Charles A., US
LIM, Jongwon, US
MACLEAN, John K. F., GB
MANSOOR, Umar F., US
NORTHRUP, Alan B., US
SANDERS, John M., US
SMITH, Graham F., US
TORRES, Luis, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
(54) | INHIBITORS OF IRAK4 ACTIVITY |
INHIBITORS OF IRAK4 ACTIVITY |